Emily K. Kozera
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Lichenoid drug reaction to technicium-99: a case report and review of the literature.
Journal: International journal of women's dermatology
Published: February 29, 2024
Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia.
Journal: Dermatology (Basel, Switzerland)
Published: January 20, 2024
Mast cells are upregulated in hidradenitis suppurativa tissue, associated with epithelialized tunnels and normalized by spleen tyrosine kinase antagonism.
Journal: Experimental dermatology
Published: March 30, 2023
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa.
Journal: Journal of the American Academy of Dermatology
Published: January 30, 2023
Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort study.
Journal: Experimental dermatology
Published: January 24, 2023
Infectious Disease Screening prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation.
Journal: Dermatology (Basel, Switzerland)
Published: October 19, 2022
Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: September 12, 2022
The impact of psoriasis biologic therapy on HIV viral load and CD4+ cell counts in HIV-positive individuals: A real-world cohort study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 28, 2022
Strongyloides screening prior to dupilumab therapy in atopic dermatitis: a retrospective cohort study evaluating screening utility.
Journal: The British journal of dermatology
Published: July 13, 2022
Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: June 10, 2022
Extramammary Paget's disease: Harbinger of internal malignancy.
Journal: Australian journal of general practice
Published: May 02, 2022
Last Updated: 09/26/2026